
Delcath Systems DCTH
$ 10.86
0.28%
Annual report 2025
added 02-26-2026
Delcath Systems General and Administrative Expenses 2011-2026 | DCTH
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Delcath Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.5 M | 29.6 M | 22.1 M | 17.3 M | 13.6 M | 11.1 M | 11.3 M | 9.82 M | 9.68 M | 9.43 M | 10 M | 15.8 M | 20.7 M | 28 M | 21.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 43.5 M | 9.43 M | 18.2 M |
Quarterly General and Administrative Expenses Delcath Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.3 M | 11.4 M | 11.3 M | - | 6.95 M | 6.76 M | 8.81 M | - | 6.2 M | 4.79 M | 4.16 M | - | 4.78 M | 4.5 M | 4.2 M | - | 4.04 M | 3.29 M | 3.3 M | - | 2 M | 2.26 M | 2.32 M | - | 4 M | 2.65 M | 2.55 M | - | 2.28 M | 2.64 M | 2.37 M | - | 2.86 M | 2.53 M | 2.42 M | - | 2.36 M | 2.29 M | 2.38 M | - | 2.28 M | 2.5 M | 3.04 M | - | 4.54 M | 4.6 M | 3.82 M | - | 4.57 M | 6.26 M | 6.08 M | - | 6.96 M | 7.22 M | 7.42 M | - | 5.74 M | 5.24 M | 4.17 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11.4 M | 2 M | 4.6 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
1.76 B | $ 190.07 | 2.73 % | $ 14.2 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | ||
|
AdaptHealth Corp.
AHCO
|
382 M | $ 12.66 | 0.64 % | $ 1.71 B | ||
|
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | ||
|
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | ||
|
BioSig Technologies
BSGM
|
67.5 M | - | 37.08 % | $ 85.7 M | ||
|
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.49 | -2.79 % | $ 131 M | ||
|
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
6.89 B | $ 64.23 | 1.28 % | $ 95.1 B | ||
|
Electromed
ELMD
|
39.3 M | $ 26.06 | 2.64 % | $ 220 M | ||
|
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.66 | 8.2 % | $ 41.1 M | ||
|
ClearPoint Neuro
CLPT
|
16.5 M | $ 11.79 | 12.29 % | $ 334 M | ||
|
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | ||
|
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | ||
|
OrthoPediatrics Corp.
KIDS
|
120 M | $ 16.75 | 1.33 % | $ 393 M | ||
|
Second Sight Medical Products
EYES
|
1.11 M | - | -0.97 % | $ 54.4 M | ||
|
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | ||
|
LENSAR
LNSR
|
45.2 M | $ 5.93 | 2.24 % | $ 70.9 M | ||
|
GBS
GBS
|
8.88 M | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
1.18 B | $ 95.25 | 2.7 % | $ 12.9 B | ||
|
Helius Medical Technologies
HSDT
|
9.27 M | $ 2.12 | 2.91 % | $ 1.29 M | ||
|
Butterfly Network
BFLY
|
39.8 M | $ 5.45 | 3.02 % | $ 1.15 B | ||
|
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | ||
|
Inogen
INGN
|
67.4 M | $ 6.82 | 3.49 % | $ 181 M | ||
|
IRIDEX Corporation
IRIX
|
7.73 M | $ 1.06 | 1.92 % | $ 18 M | ||
|
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | ||
|
Inspire Medical Systems
INSP
|
625 M | $ 57.59 | 2.02 % | $ 1.69 B | ||
|
CONMED Corporation
CNMD
|
132 M | $ 39.08 | 3.09 % | $ 1.21 B | ||
|
LivaNova PLC
LIVN
|
549 M | $ 67.12 | 3.25 % | $ 3.66 B | ||
|
Integer Holdings Corporation
ITGR
|
212 M | $ 90.2 | 2.07 % | $ 3.13 B | ||
|
FONAR Corporation
FONR
|
23.5 M | $ 18.8 | 0.21 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
227 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
2.09 B | $ 80.99 | 2.45 % | $ 47.4 B | ||
|
Sintx Technologies
SINT
|
6.2 M | $ 2.7 | 0.75 % | $ 7.49 M | ||
|
Penumbra
PEN
|
663 M | $ 332.13 | 0.2 % | $ 12.9 B | ||
|
Cutera
CUTR
|
63.3 M | - | -10.19 % | $ 1.99 M |